Haemonetics (HAE) Misses Q4 EPS by 21c, Revenues Beat; Offers FY22 EPS Guidance Above Consensus
Go back to Haemonetics (HAE) Misses Q4 EPS by 21c, Revenues Beat; Offers FY22 EPS Guidance Above Consensus| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 90.80 +0.42 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.38 | 52 Week High | $39.41 | |||
| Open | $90.61 | 52 Week Low | $25.98 | |||
| Day High | $91.49 | P/E | 127.89 | |||
| Day Low | $89.82 | EPS | $0.71 | |||
| Volume | 533,284 | |||||
